Study of ProACT implant for long-term urine leak control
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study follows men who have urine leakage from stress (leakage with movement/coughing) after prostate surgery and receive a ProACT device. It looks at long-term outcomes over 5 years and checks safety, including for those who may need device removal or other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man at least 50 years old.
- You have stress urinary incontinence (urine leaks with activity or pressure).
- You previously had prostate surgery (like radical prostatectomy or TURP).
- You can and agree to have ProACT surgically implanted and do yearly phone follow-ups for 5 years, even if the device is removed or you get other treatments.
- Your urine test is negative for infection, and you have specific proof of leakage on two 24-hour pad tests.
- Your PSA blood test results and prostate cancer history fit the study rules, and your doctor feels you are a good surgical candidate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new artificial urinary sphincter (a device that helps control urine flow) for men with severe stress incontinence (leakage during activity) that has lasted over a year. If you qualify, the device is implanted to help you stay dry. It is not for everyone, so the study will check your health history carefully.
This study follows people who choose surgery using a synthetic under-the-urethra vaginal sling for stress urinary incontinence (urine leakage with coughing or exertion). It aims to track outcomes over time and help confirm the sling is safe and works as intended.
This trial tests a non-surgical, non-drug treatment that uses gentle electrical stimulation on the skin to help strengthen the muscles that control urine leakage. It's for men who still have urinary incontinence at least 6 months after their prostate cancer treatment.
This study tests a new device called UrOActive that helps men with stress urinary incontinence (leaking urine when coughing, sneezing, or moving). It aims to see if the device is safe and works well to control leaks.
This study tests a non-invasive (no surgery or needles) electrical stimulation device to help men regain bladder control after prostate removal surgery. The device uses gentle electrical pulses on the pelvic floor muscles to retrain them and reduce urine leakage.
This trial tests an adjustable treatment to reduce stress urinary incontinence (urine leaking when you cough, sneeze, or exercise). It’s for women who still leak after trying other treatments and who may be able to have surgery, while excluding certain bladder problems and health risks.
Hear when a new Stress Urinary Incontinence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.